{
  "id": 1599,
  "text": "1151</td><td>2000</td><td>26</td><td> Bleomycin/mitomycin C/cisplatin</td><td>73.1</td><td></td><td>nr</td></tr><tr><td>Sugiyama et al.1511</td><td>1999</td><td>23</td><td>Cisplatin/irinotecan</td><td>78</td><td>nr nr </td><td>5-year: 80</td></tr><tr><td>Zanetta et al.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: 1151</td><td>2000</td><td>26</td><td> Bleomycin/mitomycin C/cisplatin</td><td>73.1</td><td></td><td>nr</td></tr><tr><td>Sugiyama et al.1511</td><td>1999</td><td>23</td><td>Cisplatin/irinotecan</td><td>78</td><td>nr nr </td><td>5-year: 80</td></tr><tr><td>Zanetta et al.\n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "根据现有数据，Bleomycin/mitomycin C/cisplatin联合疗法的五年生存率为73.1%；而Cisplatin/irinotecan联合疗法的五年生存率为80%。",
  "query": "在宫颈癌治疗中，Bleomycin/mitomycin C/cisplatin联合疗法和Cisplatin/irinotecan联合疗法的五年生存率分别是多少？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 在宫颈癌治疗中，Bleomycin/mitomycin C/cisplatin联合疗法和Cisplatin/irinotecan联合疗法的五年生存率分别是多少？\n\n<reference text>: 1151</td><td>2000</td><td>26</td><td> Bleomycin/mitomycin C/cisplatin</td><td>73.1</td><td></td><td>nr</td></tr><tr><td>Sugiyama et al.1511</td><td>1999</td><td>23</td><td>Cisplatin/irinotecan</td><td>78</td><td>nr nr </td><td>5-year: 80</td></tr><tr><td>Zanetta et al.\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "根据现有数据，Bleomycin/mitomycin C/cisplatin联合疗法的五年生存率为73.1%；而Cisplatin/irinotecan联合疗法的五年生存率为80%。"
}